Cargando…
Drug-Based Lead Discovery: The Novel Ablative Antiretroviral Profile of Deferiprone in HIV-1-Infected Cells and in HIV-Infected Treatment-Naive Subjects of a Double-Blind, Placebo-Controlled, Randomized Exploratory Trial
Antiretrovirals suppress HIV-1 production yet spare the sites of HIV-1 production, the HIV-1 DNA-harboring cells that evade immune detection and enable viral resistance on-drug and viral rebound off-drug. Therapeutic ablation of pathogenic cells markedly improves the outcome of many diseases. We ext...
Autores principales: | Saxena, Deepti, Spino, Michael, Tricta, Fernando, Connelly, John, Cracchiolo, Bernadette M., Hanauske, Axel-Rainer, D’Alliessi Gandolfi, Darlene, Mathews, Michael B., Karn, Jonathan, Holland, Bart, Park, Myung Hee, Pe’ery, Tsafi, Palumbo, Paul E., Hanauske-Abel, Hartmut M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4871512/ https://www.ncbi.nlm.nih.gov/pubmed/27191165 http://dx.doi.org/10.1371/journal.pone.0154842 |
Ejemplares similares
-
Inhibition of HIV-1 gene expression by Ciclopirox and Deferiprone, drugs that prevent hypusination of eukaryotic initiation factor 5A
por: Hoque, Mainul, et al.
Publicado: (2009) -
Drug-Induced Reactivation of Apoptosis Abrogates HIV-1 Infection
por: Hanauske-Abel, Hartmut M., et al.
Publicado: (2013) -
Deferiprone‐induced agranulocytosis: 20 years of clinical observations
por: Tricta, Fernando, et al.
Publicado: (2016) -
Cost–Utility Analysis of Deferiprone for the Treatment of β-Thalassaemia Patients with Chronic Iron Overload: A UK Perspective
por: Bentley, Anthony, et al.
Publicado: (2013) -
Induction of p53, p21 and apoptosis by silencing the NF90/NF45 complex in human papilloma virus-transformed cervical carcinoma cells
por: Shamanna, Raghavendra A., et al.
Publicado: (2012)